Propafenone Hydrochloride Capsule, Extended Release
Product Images NDC 0832-0741

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Propafenone Hydrochloride (NDC 0832-0741). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Upsher-smith Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Propafenone 01)

Chemical structure diagram of Propafenone Hydrochloride showing its molecular framework with labeled functional groups and bonds.*

FDA Label Image

Figure 1 (Propafenone 02)

A Kaplan-Meier curve graph showing the proportion of patients without event over days up to around 275 days for placebo and three dosages of Propafenone Hydrochloride extended release capsules (225 mg, 325 mg, and 425 mg twice daily). The graph includes a table of patients at risk at several time points and statistical significance annotations (p-values) comparing treatment groups to placebo.*

FDA Label Image

Principal Display Panel (225 mg Capsule Bottle Label)

Label for Propafenone Hydrochloride Extended-Release Capsules, USP 225 mg, containing 60 capsules. The label includes handling and storage instructions, manufacturer information for Upsher-Smith Laboratories, LLC, and a barcode. The capsules are for oral use and prescription only.*

FDA Label Image

Principal Display Panel (325 mg Capsule Bottle Label)

Packaging label for Propafenone Hydrochloride Extended-Release Capsules, USP, 325 mg strength. The label indicates a quantity of 60 capsules, Rx only, manufactured by Upsher-Smith Laboratories, LLC. Dosage information and storage instructions are partially visible along with a barcode and the NDC number 0832-0741-60.*

FDA Label Image

Principal Display Panel (425 mg Capsule Bottle Label)

Label for Propafenone Hydrochloride Extended-Release Capsules, USP 425 mg by Upsher-Smith Laboratories, LLC. The label indicates the package contains 60 capsules and includes storage instructions, dosage information reference, and a barcode. The label features the Upsher-Smith brand logo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.